We’re the world’s first transomics company helping researchers and drug developers discover new drugs, rediscover new uses for existing therapeutics, and rescue drugs that may be on a course toward failing.
Learn how Pepper Bio, the ‘Waze for Drug Discovery,’ is already changing the course of therapeutic development for currently untreatable diseases.
Learn how Pepper Bio, the ‘Waze for Drug Discovery,’ is already changing the course of therapeutic development for currently untreatable diseases.
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $6.5M
Investors 4
| Date | Name | Website |
| - | NFX | nfx.com |
| 08.12.2023 | Empath Ven... | empath.vc |
| - | VSC Ventur... | vscventure... |
| - | Merck Digi... | mds.studio |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2024 | Seed | $6.5M | - |
Mentions in press and media 6
| Date | Title | Description |
| 09.01.2024 | How to find the right venture investor | Venture capitalists aren’t throwing money around like they used to. The funding environment in 2023 was rough, as investors buttoned up their pocketbooks to steel themselves for a recession. Full TechCrunch+ articles are only available to m... |
| 05.01.2024 | Pitch Deck Teardown: Pepper Bio’s $6.5M seed deck | Happy New Year, and welcome to the 78th installment of Pitch Deck Teardown! This week, we are taking a closer look at Pepper Bio‘s seed pitch deck that landed the company $6.5 million. With the slogan “The end of untreatable,” the company i... |
| 30.11.2023 | Pepper Bio, the ’Google Maps for Drug Discovery’, Secures $6.5M to Streamline R&D | What You Should Know: Pepper Bio, the “Google Maps for drug discovery,” today announced an oversubscribed $6.5 million seed round led by NFX with participation from Silverton Partners, Merck Digital Sciences Studio, Mana Ventures, Tensility... |
| 30.11.2023 | Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new funding | Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant dise... |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |
| - | Pepper Bio | “Pepper Bio makes it possible to develop cures with confidence. Join the transomic era of drug discovery. Contact us today.” |